NCT04533503 - Vis-Rx Post-Market Evaluation | Biotech Hunter

Enrollment

257

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

January 25, 2023

Study Completion Date

January 25, 2023

Conditions

Coronary Artery Disease

Interventions

DEVICE

HF-OCT Imaging with the Vis-Rx Micro-Imaging Catheter

Intracoronary HF-OCT imaging of the target lesion(s) during the procedure.

Trial Locations (3)

University of South Florida, Tampa

Baptist Health Lexington, Lexington

Dartmouth-Hitchcock Medical Center, Lebanon